Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Industry To FDA: Limit Scope Of Branding Provision To Reprocessed Devices
Mar 17 2003
More from Archive
More from Medtech Insight